280 related articles for article (PubMed ID: 12151550)
1. Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.
Ballard TM; Pauly-Evers M; Higgins GA; Ouagazzal AM; Mutel V; Borroni E; Kemp JA; Bluethmann H; Kew JN
J Neurosci; 2002 Aug; 22(15):6713-23. PubMed ID: 12151550
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site.
Kew JN; Koester A; Moreau JL; Jenck F; Ouagazzal AM; Mutel V; Richards JG; Trube G; Fischer G; Montkowski A; Hundt W; Reinscheid RK; Pauly-Evers M; Kemp JA; Bluethmann H
J Neurosci; 2000 Jun; 20(11):4037-49. PubMed ID: 10818139
[TBL] [Abstract][Full Text] [Related]
3. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.
Labrie V; Clapcote SJ; Roder JC
Pharmacol Biochem Behav; 2009 Feb; 91(4):610-20. PubMed ID: 18940194
[TBL] [Abstract][Full Text] [Related]
4. Structural consequences of D481N/K483Q mutation at glycine binding site of NMDA ionotropic glutamate receptors: a molecular dynamics study.
Blaise MC; Bhattacharyya D; Sowdhamini R; Pradhan N
J Biomol Struct Dyn; 2005 Feb; 22(4):399-410. PubMed ID: 15588104
[TBL] [Abstract][Full Text] [Related]
5. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia.
Labrie V; Lipina T; Roder JC
Psychopharmacology (Berl); 2008 Oct; 200(2):217-30. PubMed ID: 18597079
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
[TBL] [Abstract][Full Text] [Related]
8. Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons.
Baptista V; Varanda WA
J Neurophysiol; 2005 Jul; 94(1):147-52. PubMed ID: 15744010
[TBL] [Abstract][Full Text] [Related]
9. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
[TBL] [Abstract][Full Text] [Related]
10. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.
Tsai G; Ralph-Williams RJ; Martina M; Bergeron R; Berger-Sweeney J; Dunham KS; Jiang Z; Caine SB; Coyle JT
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8485-90. PubMed ID: 15159536
[TBL] [Abstract][Full Text] [Related]
11. Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones.
Wang LY; MacDonald JF
J Physiol; 1995 Jul; 486 ( Pt 1)(Pt 1):83-95. PubMed ID: 7562646
[TBL] [Abstract][Full Text] [Related]
12. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit.
Miyamoto Y; Yamada K; Noda Y; Mori H; Mishina M; Nabeshima T
J Neurosci; 2001 Jan; 21(2):750-7. PubMed ID: 11160454
[TBL] [Abstract][Full Text] [Related]
13. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
14. Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile.
Yee BK; Balic E; Singer P; Schwerdel C; Grampp T; Gabernet L; Knuesel I; Benke D; Feldon J; Mohler H; Boison D
J Neurosci; 2006 Mar; 26(12):3169-81. PubMed ID: 16554468
[TBL] [Abstract][Full Text] [Related]
15. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.
Chen L; Muhlhauser M; Yang CR
J Neurophysiol; 2003 Feb; 89(2):691-703. PubMed ID: 12574447
[TBL] [Abstract][Full Text] [Related]
16. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
17. Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.
Labrie V; Wang W; Barger SW; Baker GB; Roder JC
Genes Brain Behav; 2010 Feb; 9(1):11-25. PubMed ID: 19751394
[TBL] [Abstract][Full Text] [Related]
18. Glycine binding sites of presynaptic NMDA receptors may tonically regulate glutamate release in the rat visual cortex.
Li YH; Han TZ
J Neurophysiol; 2007 Jan; 97(1):817-23. PubMed ID: 17093111
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
[TBL] [Abstract][Full Text] [Related]
20. D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning.
Duffy S; Labrie V; Roder JC
Neuropsychopharmacology; 2008 Apr; 33(5):1004-18. PubMed ID: 17625504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
